Clinical Trial Update: Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the combination of capecitabine and fulvestrant in postmenopausal women with hormone receptor-positive metastatic breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-02-01